Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice.

Kozuka, Chisayo

Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice. [electronic resource] - Drug delivery Nov 2017 - 558-568 p. digital

Publication Type: Journal Article

1521-0464

10.1080/10717544.2017.1279237 doi


Administration, Oral
Animals
Behavior, Animal--drug effects
Blood Glucose--drug effects
Diabetes Mellitus--blood
Disease Models, Animal
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Carriers
Drug Compounding
Endoplasmic Reticulum Stress--drug effects
Energy Metabolism--drug effects
Food Preferences--drug effects
Gastrointestinal Microbiome--drug effects
Hypoglycemic Agents--administration & dosage
Hypolipidemic Agents--administration & dosage
Insulin Resistance
Intestinal Absorption
Islets of Langerhans--drug effects
Lactic Acid--administration & dosage
Lipids--blood
Liver--drug effects
Male
Mice, Obese
Nanomedicine
Nanoparticles
Obesity--blood
Phenylpropionates--administration & dosage
Polyglycolic Acid--administration & dosage
Polylactic Acid-Polyglycolic Acid Copolymer
Solubility
Technology, Pharmaceutical--methods
Time Factors